 |
PDBsum entry 2og3
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Viral protein
|
PDB id
|
|
|
|
2og3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Virol
81:3913-3921
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Ribonucleocapsid formation of severe acute respiratory syndrome coronavirus through molecular action of the N-terminal domain of N protein.
|
|
K.S.Saikatendu,
J.S.Joseph,
V.Subramanian,
B.W.Neuman,
M.J.Buchmeier,
R.C.Stevens,
P.Kuhn.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Conserved among all coronaviruses are four structural proteins: the matrix (M),
small envelope (E), and spike (S) proteins that are embedded in the viral
membrane and the nucleocapsid phosphoprotein (N), which exists in a
ribonucleoprotein complex in the lumen. The N-terminal domain of coronaviral N
proteins (N-NTD) provides a scaffold for RNA binding, while the C-terminal
domain (N-CTD) mainly acts as oligomerization modules during assembly. The C
terminus of the N protein anchors it to the viral membrane by associating with M
protein. We characterized the structures of N-NTD from severe acute respiratory
syndrome coronavirus (SARS-CoV) in two crystal forms, at 1.17 A (monoclinic) and
at 1.85 A (cubic), respectively, resolved by molecular replacement using the
homologous avian infectious bronchitis virus (IBV) structure. Flexible loops in
the solution structure of SARS-CoV N-NTD are now shown to be well ordered around
the beta-sheet core. The functionally important positively charged beta-hairpin
protrudes out of the core, is oriented similarly to that in the IBV N-NTD, and
is involved in crystal packing in the monoclinic form. In the cubic form, the
monomers form trimeric units that stack in a helical array. Comparison of
crystal packing of SARS-CoV and IBV N-NTDs suggests a common mode of RNA
recognition, but they probably associate differently in vivo during the
formation of the ribonucleoprotein complex. Electrostatic potential distribution
on the surface of homology models of related coronaviral N-NTDs suggests that
they use different modes of both RNA recognition and oligomeric assembly,
perhaps explaining why their nucleocapsids have different morphologies.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.W.Neuman,
G.Kiss,
A.H.Kunding,
D.Bhella,
M.F.Baksh,
S.Connelly,
B.Droese,
J.P.Klaus,
S.Makino,
S.G.Sawicki,
S.G.Siddell,
D.G.Stamou,
I.A.Wilson,
P.Kuhn,
and
M.J.Buchmeier
(2011).
A structural analysis of M protein in coronavirus assembly and morphology.
|
| |
J Struct Biol,
174,
11-22.
|
 |
|
|
|
|
 |
S.Zúñiga,
J.L.Cruz,
I.Sola,
P.A.Mateos-Gómez,
L.Palacio,
and
L.Enjuanes
(2010).
Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription.
|
| |
J Virol,
84,
2169-2175.
|
 |
|
|
|
|
 |
T.J.Cowley,
S.Y.Long,
and
S.R.Weiss
(2010).
The murine coronavirus nucleocapsid gene is a determinant of virulence.
|
| |
J Virol,
84,
1752-1763.
|
 |
|
|
|
|
 |
Y.P.Zhang,
R.W.Zhang,
W.S.Chang,
and
Y.Y.Wang
(2010).
Cxcl16 interact with SARS-CoV N protein in and out cell.
|
| |
Virol Sin,
25,
369-374.
|
 |
|
|
|
|
 |
C.K.Chang,
Y.L.Hsu,
Y.H.Chang,
F.A.Chao,
M.C.Wu,
Y.S.Huang,
C.K.Hu,
and
T.H.Huang
(2009).
Multiple nucleic acid binding sites and intrinsic disorder of severe acute respiratory syndrome coronavirus nucleocapsid protein: implications for ribonucleocapsid protein packaging.
|
| |
J Virol,
83,
2255-2264.
|
 |
|
|
|
|
 |
C.Y.Huang,
Y.L.Hsu,
W.L.Chiang,
and
M.H.Hou
(2009).
Elucidation of the stability and functional regions of the human coronavirus OC43 nucleocapsid protein.
|
| |
Protein Sci,
18,
2209-2218.
|
 |
|
|
|
|
 |
H.I.Liao,
C.A.Olson,
S.Hwang,
H.Deng,
E.Wong,
R.S.Baric,
R.W.Roberts,
and
R.Sun
(2009).
mRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid protein.
|
| |
J Biol Chem,
284,
17512-17520.
|
 |
|
|
|
|
 |
K.R.Hurst,
C.A.Koetzner,
and
P.S.Masters
(2009).
Identification of in vivo-interacting domains of the murine coronavirus nucleocapsid protein.
|
| |
J Virol,
83,
7221-7234.
|
 |
|
|
|
|
 |
M.C.Lai,
T.Y.Peng,
and
W.Y.Tarn
(2009).
Functional interplay between viral and cellular SR proteins in control of post-transcriptional gene regulation.
|
| |
FEBS J,
276,
1517-1526.
|
 |
|
|
|
|
 |
M.W.Clarkson,
M.Lei,
E.Z.Eisenmesser,
W.Labeikovsky,
A.Redfield,
and
D.Kern
(2009).
Mesodynamics in the SARS nucleocapsid measured by NMR field cycling.
|
| |
J Biomol NMR,
45,
217-225.
|
 |
|
|
|
|
 |
N.E.Grossoehme,
L.Li,
S.C.Keane,
P.Liu,
C.E.Dann,
J.L.Leibowitz,
and
D.P.Giedroc
(2009).
Coronavirus N protein N-terminal domain (NTD) specifically binds the transcriptional regulatory sequence (TRS) and melts TRS-cTRS RNA duplexes.
|
| |
J Mol Biol,
394,
544-557.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Canard,
J.S.Joseph,
and
P.Kuhn
(2008).
International research networks in viral structural proteomics: again, lessons from SARS.
|
| |
Antiviral Res,
78,
47-50.
|
 |
|
|
|
|
 |
B.W.Neuman,
J.S.Joseph,
K.S.Saikatendu,
P.Serrano,
A.Chatterjee,
M.A.Johnson,
L.Liao,
J.P.Klaus,
J.R.Yates,
K.Wüthrich,
R.C.Stevens,
M.J.Buchmeier,
and
P.Kuhn
(2008).
Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3.
|
| |
J Virol,
82,
5279-5294.
|
 |
|
|
|
|
 |
C.Zhang,
O.Crasta,
S.Cammer,
R.Will,
R.Kenyon,
D.Sullivan,
Q.Yu,
W.Sun,
R.Jha,
D.Liu,
T.Xue,
Y.Zhang,
M.Moore,
P.McGarvey,
H.Huang,
Y.Chen,
J.Zhang,
R.Mazumder,
C.Wu,
and
B.Sobral
(2008).
An emerging cyberinfrastructure for biodefense pathogen and pathogen-host data.
|
| |
Nucleic Acids Res,
36,
D884-D891.
|
 |
|
|
|
|
 |
J.Pan,
X.Peng,
Y.Gao,
Z.Li,
X.Lu,
Y.Chen,
M.Ishaq,
D.Liu,
M.L.Dediego,
L.Enjuanes,
and
D.Guo
(2008).
Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV replication.
|
| |
PLoS ONE,
3,
e3299.
|
 |
|
|
|
|
 |
M.Bartlam,
X.Xue,
and
Z.Rao
(2008).
The search for a structural basis for therapeutic intervention against the SARS coronavirus.
|
| |
Acta Crystallogr A,
64,
204-213.
|
 |
|
|
|
|
 |
M.Bartlam,
Y.Xu,
and
Z.Rao
(2007).
Structural proteomics of the SARS coronavirus: a model response to emerging infectious diseases.
|
| |
J Struct Funct Genomics,
8,
85-97.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |